Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00004891 · ClinicalTrials.gov registry record · NA

PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery

A NA study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
149
Enrollment target

NCT00004891: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00004891 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 149 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00004891, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
149 participants
Enrollment target

Study Summary

RATIONALE: Diagnostic procedures, such as PET and CT scans, may improve the ability to detect the extent of locally advanced primary rectal cancer and may also help to measure a patient's response to treatment. PURPOSE: This clinical trial is studying how well PET and CT scans detect residual or metastatic disease in patients with locally advanced primary rectal cancer that can be removed during surgery.

Interventions

  • PROCEDURE positron emission tomography
  • PROCEDURE computed tomography
  • PROCEDURE conventional surgery
  • DRUG chemotherapy
  • PROCEDURE neoadjuvant therapy

Trial Details

FieldValue
Enrollment Target 149 participants
Start Date 1999-09
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00004891

The ClinicalTrials.gov registry entry for NCT00004891 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which positron emission tomography is the first listed.

NCT00004891 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00004891 about?

NCT00004891 is a clinical study titled "PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery". RATIONALE: Diagnostic procedures, such as PET and CT scans, may improve the ability to detect the extent of locally advanced primary rectal cancer and may also help to measure a patient's response to treatment. PURPOSE: This clinical trial is studying how well PET and CT scans detect residual or me...

What is the current status of trial NCT00004891?

This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 1999-09.

What interventions are being tested in trial NCT00004891?

The interventions under investigation include: positron emission tomography (PROCEDURE), computed tomography (PROCEDURE), conventional surgery (PROCEDURE), chemotherapy (DRUG), neoadjuvant therapy (PROCEDURE).

Who is sponsoring clinical trial NCT00004891?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.